These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19808721)

  • 1. Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months.
    Lookstein RA; Talenfeld AD; Raju R; Vorchheimer DA; Olin JW; Marin ML
    Vasc Med; 2009 Nov; 14(4):361-4. PubMed ID: 19808721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.
    Zähringer M; Sapoval M; Pattynama PM; Rabbia C; Vignali C; Maleux G; Boyer L; Szczerbo-Trojanowska M; Jaschke W; Hafsahl G; Downes M; Bérégi JP; Veeger NJ; Stoll HP; Talen A
    J Endovasc Ther; 2007 Aug; 14(4):460-8. PubMed ID: 17696619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents.
    Kiernan TJ; Yan BP; Eisenberg JD; Ruggiero NJ; Gupta V; Drachman D; Schainfeld RM; Jaff MR; Rosenfield K; Garasic J
    Vasc Med; 2010 Feb; 15(1):3-7. PubMed ID: 19793778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent insertion in the treatment of in-stent renal artery restenosis in three renal transplant recipients.
    Douis H; Shabir S; Lipkin G; Riley P
    J Vasc Interv Radiol; 2008 Dec; 19(12):1757-60. PubMed ID: 18952465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty.
    Zeller T; Sixt S; Rastan A; Schwarzwälder U; Müller C; Frank U; Bürgelin K; Schwarz T; Hauswald K; Brantner R; Noory E; Neumann FJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):296-300. PubMed ID: 17630674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone.
    N'Dandu ZM; Badawi RA; White CJ; Grise MA; Reilly JP; Jenkins JS; Collins TJ; Ramee SR
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):701-5. PubMed ID: 18360868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A revisit: repeat stent placement versus angioplasty alone for renal in-stent restenosis.
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):706-7. PubMed ID: 18360869
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease.
    Bradaric C; Eser K; Preuss S; Dommasch M; Wustrow I; Langwieser N; Haller B; Ott I; Fusaro M; Heemann U; Laugwitz KL; Kastrati A; Ibrahim T
    EuroIntervention; 2017 Jun; 13(2):e248-e255. PubMed ID: 28044987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to treat recurrent renal artery instent restenosis? Editorial comment on treatment of reoccuring instent restenosis following reintervention after stent-supported renal artery angioplasty--article by Zeller et al.
    Schillinger M
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):301-2. PubMed ID: 17630675
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon-expandable covered stent therapy of complex endovascular pathology.
    Giles H; Lesar C; Erdoes L; Sprouse R; Myers S
    Ann Vasc Surg; 2008 Nov; 22(6):762-8. PubMed ID: 18922676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal artery stent fracture with refractory hypertension: a case report and review of the literature.
    Chua SK; Hung HF
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):37-42. PubMed ID: 19530182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization in a 17-Year-Old Girl with Neurofibromatosis and Severe Hypertension Caused by Renal Artery Stenosis.
    Beladan CC; Geavlete OD; Botezatu S; Postu M; Popescu BA; Ginghina C; Coman IM
    Tex Heart Inst J; 2017 Feb; 44(1):50-54. PubMed ID: 28265213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?
    Zeller T; Rastan A; Rothenpieler U; Müller C
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):125-30. PubMed ID: 16755597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular brachytherapy for renal artery in-stent restenosis.
    Silverman SH; Exline JB; Silverman LN; Samson RH
    J Vasc Surg; 2014 Dec; 60(6):1599-604. PubMed ID: 25284630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent for recurrent mesenteric artery in-stent restenosis.
    Cardaioli P; Rigatelli G; Zattoni L; Giordan M
    J Endovasc Ther; 2007 Oct; 14(5):748-51. PubMed ID: 17924744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.